<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01400009</url>
  </required_header>
  <id_info>
    <org_study_id>D-STAT-2010</org_study_id>
    <nct_id>NCT01400009</nct_id>
  </id_info>
  <brief_title>Vitamin D Replacement in Statin-Induced Myopathy</brief_title>
  <official_title>Vitamin D Replacement in Statin-Induced Myopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pretreating people with replacement doses of vitamin D will allow them to tolerate Statin
      medications that have caused muscle pain for them in the past.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who have been unable to tolerate statin medications due to muscle pain will be
      randomly assigned to receive vitamin D or placebo for 6 weeks before reintroducing their
      statin medication. The investigators will judge whether vitamin D in the manner administered
      in the study reduces the myalgia with statins and allows patients to remain on these
      important medications.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    lack of enrollment
  </why_stopped>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lack of need to stop statin medication due to myalgia</measure>
    <time_frame>12 weeks</time_frame>
    <description>Ability to tolerate a statin at the same dosage that previously caused the individuals to stop due to myalgia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reduction of visual analog pain score</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>HMG COA Reductase Inhibitor Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects in this group will receive a placebo tablet (Lactose 100 mg) for the duration of the study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm will receive a dose of 50,000 IU of vitamin D3, followed by weekly doses of 10,000 IU of vitamin D3</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D (Cholecalciferol )</intervention_name>
    <description>10,000 IU tablets. 50,000 initial dose, followed by weekly doses of 10,000 IU</description>
    <arm_group_label>Vitamin D</arm_group_label>
    <other_name>DIN number 00821772</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Standard Placebo made of Lactose 100 mg</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Lactose 100 mg DIN 00501190</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male and female adults

          -  identified by their physician as having myalgia with their statin medication.

        Exclusion Criteria:

          -  Unexplained CK &gt; 4X upper limit of normal, at study entry, or on a statin medication
             in the past.

          -  Severe myositis

          -  Consumption in excess of 14 alcoholic beverages per week

          -  Situations which will cause difficulty in interpreting the vitamin D and / or PTH.

        examples:

          -  Present consumption of vitamin D supplements &gt; 1000 iu daily

          -  Renal impairment (Estimated creatinine clearance &lt; 70 ± 14 mL/min/m2 in Males; and &lt;
             60 ± 10 mL/min/m2 in Females)

          -  Chronic liver disease or impaired liver function

          -  Any contraindication for statin re-challenge Example: rhabdomyolysis or allergy to
             statins
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark H Sherman, MD,CM</last_name>
    <role>Study Chair</role>
    <affiliation>McGill University Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MUHC-Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2011</study_first_submitted>
  <study_first_submitted_qc>July 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2011</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Center</investigator_affiliation>
    <investigator_full_name>Dr. Mark Sherman</investigator_full_name>
    <investigator_title>Associate Professor (Clinical), Dept of Medicine</investigator_title>
  </responsible_party>
  <keyword>Statin</keyword>
  <keyword>HMG COA Reductase Inhibitor</keyword>
  <keyword>myalgia</keyword>
  <keyword>vitamin D</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

